Background: Between June 2006 and March 2017 the claimant worked for a global investment banking firm, Jefferies Ltd ("Jefferies") as a research analyst in the equity market. On 19 November 2009, he was diagnosed with acute myeloid leukaemia ("AML") In May 2015 he commenced proceedings in the Employment Tribunal alleging disability discrimination against Jefferies, the disability in question being AML. His claim was comprehensively dismissed. The Tribunal found that in a number of respects the claimant had not told the truth and that he had intentionally misled the Tribunal. A contested detailed costs assessment followed and those costs were the subject of this claim.

To continue reading you must be an EWI member, become a member and access exclusive content. 

Already a member? Login